Skip to main content
News Directory 3
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Pandemic & Heavy Periods: Cochrane Review Interventions

Pandemic & Heavy Periods: Cochrane Review Interventions

June 2, 2025 Health


Treatments for Heavy Menstrual Bleeding: A Review⁣ of Options











Key Points

  • NSAIDs may reduce heavy menstrual bleeding compared to placebo.
  • Antifibrinolytics appear more effective than placebo ⁢in reducing heavy menstrual ​bleeding.
  • Combined hormonal‌ contraceptives are more effective than placebo for heavy menstrual bleeding.

Effective Treatments for Heavy Menstrual Bleeding: What the Evidence Says

Updated June⁢ 2,​ 2025
​

for women ‌experiencing heavy ⁢menstrual bleeding, several treatment options offer relief. A review of ⁤multiple studies examined the effectiveness of non-steroidal anti-inflammatory ‌drugs ​(NSAIDs), antifibrinolytics, and combined hormonal contraceptives in managing this common condition.

NSAIDs may provide some benefit compared to a placebo, reducing menstrual blood loss.Though, their effectiveness appears similar to naproxen or combined hormonal contraceptives. Notably,‌ antifibrinolytics ​seem to outperform NSAIDs in reducing‍ heavy menstrual bleeding.

Antifibrinolytics demonstrate effectiveness against heavy menstrual bleeding when compared to a placebo. Studies suggest they don’t substantially increase the risk of side effects or serious ‌adverse events like⁢ thrombotic events. Compared to short-cycle progestogens, antifibrinolytics also appear to be more effective in reducing menstrual blood loss.

Combined hormonal contraceptives show ⁤promise in managing heavy menstrual bleeding. Research indicates they are more effective than placebo or⁣ no treatment. The incidence of side ​effects appears similar to that of a placebo.

The review included data from 44⁣ randomized controlled trials involving 3,196 women, ensuring a extensive analysis of available evidence. Limitations in the evidence included risk of⁢ bias⁢ in the primary RCTs, inconsistency between the primary RCTs, and imprecision in effect estimates.

What’s next

Further research is needed to⁣ address ‌limitations⁢ and provide more‍ definitive conclusions about the optimal treatments for heavy menstrual bleeding.Future studies should focus on comparing different treatments directly and assessing their long-term effects on women’s health and quality of life.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Search:

News Directory 3

ByoDirectory is a comprehensive directory of businesses and services across the United States. Find what you need, when you need it.

Quick Links

  • Copyright Notice
  • Disclaimer
  • Terms and Conditions

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 News Directory 3. All rights reserved.

Privacy Policy Terms of Service